Success Story: EB-1A Approval in 1 Month and 5 Days for a Senior Machine Learning Scientist Advancing AI for Drug Discovery
Client’s Testimonial:
"As a self-petitioner with no employer sponsoring my case, I wasn't sure my research — spanning AI security and AI-driven drug discovery — could be tied into a single, compelling EB-1A narrative. Wegreened did exactly that. They took the time to understand my work, emphasized the contributions that mattered most, and kept the process clear and responsive throughout. My petition was approved in just over a month under premium processing.”
On May 18th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Machine Learning Scientist in the Field of Artificial Intelligence (Approval Notice).
General Field: Artificial Intelligence
Position at the Time of Case Filing: Senior Machine Learning Scientist
Country of Origin: China
State of Residence at the Time of Filing: New York
Approval Notice Date: May 18th, 2026
Processing Time: 1 month, 5 days (Premium Processing Requested)
Case Summary:
Artificial intelligence is reshaping how researchers protect large language models, analyze biomedical data, and accelerate drug discovery. For this EB-1A case, North America Immigration Law Group (Chen Immigration Law Associates) helped a senior machine learning scientist from China present a record of achievement that placed him among the top researchers in this fast-moving field.
The client held a Ph.D. in computer science and had built a distinguished career in large language models, autonomous AI, biomedical information extraction, clinical prediction, and AI-driven drug discovery.
The petition emphasized several key achievements:
- 2 peer-reviewed journal articles. 29 peer-reviewed conference articles and 7 preprints
- 1,600+ citations
- Citation record within the top 1% of Computer Science authors
- At least 70 completed peer reviews
- Research funding from the National Science Foundation, the National Institutes of Health, and the Defense Advanced Research Projects Agency
We highlighted the profound systemic impact of the client’s original contributions. His work focuses on identifying security vulnerabilities in advanced artificial intelligence architectures, developing model verification methods, mitigating algorithmic bias, optimizing clinical data extraction, and engineering autonomous AI platforms for biomedical research. Notably, his automated platforms have been widely integrated into active pharmaceutical discovery pipelines by numerous industry professionals, proving that his innovations have successfully transitioned from theoretical research into impactful, real-world applications.
In the final merits analysis, NAILG showed that the client’s citation impact, peer review record, elite publication venues, independent expert support, funding history, and deployed AI technology collectively demonstrated sustained acclaim and extraordinary ability.
USCIS approved the I-140 EB-1A petition on May 18, 2026, after only 1 month and 5 days of processing, with Premium Processing requested. We are proud to have assisted this client in securing EB-1A approval and supporting his continued contributions to artificial intelligence, large language models, autonomous AI, and drug discovery innovation in the United States.